The 31st Annual Rehabilitation in Multiple Sclerosis Conference took up a question DMTs do not answer: when should treatment aim to restore lost function, and when should it aim to work around it?
IJMSC staff
Advertisement
Articles by IJMSC staff
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
The Future of Targeted Therapy in CIDP
2
FDA Grants Fast Track Designation to Safusidenib for IDH1-Mutant Glioma
3
FDA Clears Roche's Single-Biomarker Elecsys pTau217 Blood Test for Alzheimer Disease
4
FDA Grants De Novo Authorization to Avulux Lenses for Migraine Photophobia
5